Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinations
View ORCID ProfileCarolin Otto, View ORCID ProfileTatjana Schwarz, View ORCID ProfileLara M. Jeworowski, View ORCID ProfileMarie L. Schmidt, View ORCID ProfileFelix Walper, View ORCID ProfileFlorence Pache, View ORCID ProfilePatrick Schindler, View ORCID ProfileMoritz Niederschweiberer, View ORCID ProfileAndi Krumbholz, View ORCID ProfileRuben Rose, View ORCID ProfileChristian Drosten, View ORCID ProfileKlemens Ruprecht, View ORCID ProfileVictor M Corman
doi: https://doi.org/10.1101/2022.08.10.22278639
Carolin Otto
1Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Tatjana Schwarz
2Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
Lara M. Jeworowski
2Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
Marie L. Schmidt
2Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
Felix Walper
2Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
Florence Pache
1Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Patrick Schindler
1Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Moritz Niederschweiberer
1Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Andi Krumbholz
3Institute for Infection Medicine, Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
4Labor Dr. Krause und Kollegen MVZ GmbH, 24106 Kiel, Germany
Ruben Rose
3Institute for Infection Medicine, Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
Christian Drosten
2Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
Klemens Ruprecht
1Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Victor M Corman
2Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, and German Centre for Infection Research (DZIF), associated partner, Berlin, Germany
5Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany
Data Availability
Data are available upon reasonable request.
Posted August 11, 2022.
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinations
Carolin Otto, Tatjana Schwarz, Lara M. Jeworowski, Marie L. Schmidt, Felix Walper, Florence Pache, Patrick Schindler, Moritz Niederschweiberer, Andi Krumbholz, Ruben Rose, Christian Drosten, Klemens Ruprecht, Victor M Corman
medRxiv 2022.08.10.22278639; doi: https://doi.org/10.1101/2022.08.10.22278639
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinations
Carolin Otto, Tatjana Schwarz, Lara M. Jeworowski, Marie L. Schmidt, Felix Walper, Florence Pache, Patrick Schindler, Moritz Niederschweiberer, Andi Krumbholz, Ruben Rose, Christian Drosten, Klemens Ruprecht, Victor M Corman
medRxiv 2022.08.10.22278639; doi: https://doi.org/10.1101/2022.08.10.22278639
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)